T1	Participants 56 127	patients with chronic obstructive pulmonary disease at the stable phase
T2	Participants 252 330	patients with chronic obstructive pulmonary disease (COPD) at the stable phase
T3	Participants 340 369	Thirty-six patients with COPD
